Opioid responsiveness

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 1 II, 1997, Pages 154-158

  Hanks, G W ^a   Forbes, K ^a  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

cancer pain; incident pain; neuropathic pain; opioid poorly responsive pain; opioid responsive pain; opioids; paradoxical pain

Indexed keywords

FENTANYL; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; OPIATE; PHENAZOCINE;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; CANCER PAIN; CONFERENCE PAPER; DRUG EFFICACY; DRUG METABOLISM; DRUG TOLERANCE; HUMAN; NEUROPATHY; PRIORITY JOURNAL;

EID: 0031015821     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04630.x     Document Type: Conference Paper

References (28)

1. Hanks GW, Justins DM. Cancer pain: management. Lancet 1992: 396: 1031-1036.
2. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987: 59: 851-856.
3. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organisation guidelines for cancer pain relief. A 10-year prospective study. Pain 1995: 63: 65-76.
4. Jadad AR, Browman GP. The WHO Analgesic Ladder for cancer pain management. JAMA 1995: 274: 1870-1873.
5. Fallon M, Hanks GWC. Opioid-resistant pain in cancer:sense or nonsense? The Pain Clinic 1993: 6: 205-206.
6. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988: 33: 11-23.
7. Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull 1991: 47: 644-66.
8. Twycross RG. Opioid analgesics in cancer pain: current practice and controversies. Cancer Surv 1988: 7: 29-53.
9. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990: 43: 273-286.
10. Hanks GW. Opioid-responsive and opioid-non-responsive pain in cancer. Br Med Bull 1991: 47: 718-31.
11. Hanks GW. Antiemetics for terminal cancer patients. Lancet 1982: ii: 1410.
12. Morley JS, Miles JB, Wells JC, Bowsher D. Paradoxical pain. Lancet 1992: 340: 1045.
13. Bowsher D. Paradoxical pain. Br Med J 1993: 306:473-473.
14. Hanks GW. Morphine pharmacokinetics and analgesia after oral administration. Postgrad Med J 1991: 67 (Suppl 2): S60-S63.
15. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide - a potent antagonist of morphine analgesia. Life Sci 1990: 47: 579-85.
16. Gong Q-L, Hedner J, Bjorkman R, Hedner T. Morphine-3-glucuronide may functionally antagonise morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992: 48: 249-255.
17. Dickenson AH. Neurophysiology of opioid-poorly-responsive pain. In: Hanks GW (ed). Palliative Medicine: Problem areas in pain and symptom management. Cancer Surv 1994: 21: 5-16.
18. Morley JS, Watt J. The significance of M3G in the use of morphine. Annual Scientific Meeting of the Pain Society of Great Britain & Ireland, Eastbourne April 1995. Abstracts 47.
19. Hewett K, Dickenson AH, McQuay HJ. Lack of effect of morphine-3-glucuronide on the spinal antinociceptive action of morphine in the rat: an electrophysiological study. Pain 1993: 53: 59-63.
20. Osborne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Br Med J 1986: 292: 1548-1549.
21. Morgan M. The rational use of intrathecal and extradural opioids. Br J Anaesth 1989: 63: 165-188.
22. Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain 1992: 49: 87-91.
23. Crews JC, Sweeney NJ, Denson DD. Clinical efficacy of methadone in patients refractory to other μ-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 1993: 72: 2266-2272.
24. Hanks GW, Fallon MT. More on the conversion of transdermal fentanyl to morphine. J Pain Sympt Manage 1995; 10: 581-582.
25. Hanks GW, Twycross RG. Pain, the physiological antagonist of opioid analgesics. Lancet 1984; i:1477-1478.
26. Hanks GW, Twycross RG, Lloyd JW. Unexpected complication of successful nerve block. Anaesthesia 1981: 36: 37-39.
27. McQuay H, Jadad AR. Incident pain. Cancer Surv 1994: 21: 17-24.
28. Kearney MK. Experience in a hospice with patients suffering cancer pain. In: Doyle D, ed. Opioids in the treatment of cancer pain. Royal Society of Medicine Services International Congress & Symposium Services. No 146. London: RSM Services, 1990: 69-74.